26 results
424B5
ACXP
Acurx Pharmaceuticals Inc
15 Nov 23
Prospectus supplement for primary offering
4:49pm
backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether stockholders are entitled to oversubscription rights, if any
424B5
ACXP
Acurx Pharmaceuticals Inc
17 May 23
Prospectus supplement for primary offering
4:25pm
, if any;
whether there are any backstop or standby purchaser or purchasers and the terms of their commitment, if any;
whether stockholders
8-K
EX-10.2
ACXP
Acurx Pharmaceuticals Inc
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
in the Offering (the “Purchase Commitment”), the Company hereby amends, effective as of the closing of the Offering, the Existing Warrants (as defined below … is subject to the consummation of the Offering and the Holder’s satisfaction of the Purchase Commitment. In the event that either (i) the Offering
8-K
EX-1.1
lgg8u38rcmkr8u
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
PRE 14A
06rxo0rizk8ek5c c6km
17 Apr 23
Preliminary proxy
4:05pm
424B3
k2ijl2z
23 Sep 22
Prospectus supplement
8:19am
424B5
gmexy8vl37dkl8
25 Jul 22
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
o7721asxf
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
S-3
er8rzxnee1ahq sxe7z
1 Jul 22
Shelf registration
8:46am
DEF 14A
rmzsbobs
25 Apr 22
Definitive proxy
4:06pm
10-Q
46wdagzbx 6wh
13 Aug 21
Quarterly report
4:06pm
8-K
EX-3.2
9qqhq 2v1g
29 Jun 21
ACURX PHARMACEUTICALS, INC. announces pricing of $15 Million
5:00pm
424B4
r9rx 9uoukvboql
28 Jun 21
Prospectus supplement with pricing info
6:02am
S-1
yk3ts
27 May 21
IPO registration
12:00am